drugset / Trial / NCT01003431
A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)
RandomizedParallel-groupOpen-labelPrevention
Summary
This study will evaluate the immunogenicity and safety of the pertussis component of DTwP (whole-cell pertussis containing vaccine) when administered concomitantly with RotaTeq™ or Rotatrix™.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-08
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Adacel | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Rotarix | Vaccine | 1 ml | Oral |
| Comparator | Rotarix | Vaccine | 2 ml | Oral |
| Subject | Tritanrix-HepB | Vaccine | 0.5 ml | Intramuscular |